A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin’s Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)
Condition(s):Hodgkin’s Lymphoma; Primary Mediastinal Large B-cell Lymphoma (PMBCL)Last Updated:January 30, 2024Active, not recruiting